Repare Therapeutics Inc. (RPTX) Social Stream
REPARE THERAPEUTICS INC (RPTX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering RPTX.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 8 | $54 | $40 | $46.875 | $6.98 | 571.56% |
| 2021-11-11 | 8 | $54 | $40 | $46.75 | $6.98 | 569.77% |
| 2021-11-18 | 8 | $54 | $40 | $47.375 | $6.98 | 578.72% |
| 2022-01-18 | 9 | $54 | $40 | $47.375 | $6.98 | 578.72% |
| 2022-01-31 | 9 | $54 | $30 | $45.25 | $6.98 | 548.28% |
| 2022-03-02 | 9 | $54 | $30 | $44.428 | $6.98 | 536.5% |
| 2022-04-06 | 8 | $54 | $30 | $44.142 | $6.98 | 532.41% |
| 2022-04-12 | 8 | $54 | $30 | $44.142 | $6.98 | 532.41% |
| 2022-05-10 | 8 | $54 | $11 | $37.142 | $6.98 | 432.12% |
| 2022-06-02 | 9 | $54 | $13 | $38.75 | $6.98 | 455.16% |
| 2022-06-06 | 9 | $49 | $13 | $36.75 | $6.98 | 426.5% |
| 2022-08-05 | 7 | $49 | $13 | $33.833 | $6.98 | 384.71% |
| 2022-08-09 | 7 | $49 | $13 | $33.5 | $6.98 | 379.94% |
| 2022-11-10 | 6 | $49 | $13 | $33.5 | $6.98 | 379.94% |
| 2022-11-17 | 7 | $49 | $13 | $31.333 | $6.98 | 348.9% |
| 2023-01-17 | 8 | $49 | $13 | $30.857 | $6.98 | 342.08% |
| 2023-02-03 | 8 | $49 | $13 | $29 | $6.98 | 315.47% |
| 2023-03-01 | 8 | $49 | $13 | $28.857 | $6.98 | 313.42% |
| 2023-03-17 | 8 | $49 | $13 | $26.5 | $6.98 | 279.66% |
| 2023-04-19 | 7 | $30 | $13 | $22 | $6.98 | 215.19% |
| 2023-05-09 | 7 | $49 | $13 | $26.5 | $6.98 | 279.66% |
| 2023-05-14 | 7 | $49 | $11 | $26.166 | $6.98 | 274.87% |
| 2023-06-08 | 7 | $49 | $11 | $26.166 | $6.98 | 274.87% |
| 2023-08-17 | 7 | $49 | $14 | $27 | $6.98 | 286.82% |
| 2023-10-03 | 7 | $49 | $14 | $27.166 | $6.98 | 289.2% |
| 2023-11-20 | 7 | $29 | $12 | $22.166 | $6.98 | 217.56% |
| 2023-12-19 | 7 | $29 | $8 | $21.166 | $6.98 | 203.24% |
The Trend in the Analyst Price Target
RPTX's average price target has moved down $7.69 over the prior 42 weeks.
Over the past 48 weeks, RPTX's average upside potential has been 191.8%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-19 | 7 | 30 | 13 | 22.000 | 9.41 | 133.79% |
| 2023-04-21 | 7 | 49 | 13 | 26.500 | 9.57 | 176.91% |
| 2023-05-10 | 7 | 49 | 11 | 26.166 | 10.58 | 147.32% |
| 2023-09-25 | 7 | 49 | 14 | 27.166 | 12.70 | 113.91% |
| 2023-11-20 | 7 | 29 | 12 | 22.166 | 5.14 | 331.25% |
RPTX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.29 | 6 | 0 | 1 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
Over the past 13 months, RPTX's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for RPTX as an investment opportunity.
- In the context of all US stocks, REPARE THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 2668.83% of them.
- RPTX has a lower variance in analysts' estimates than -2213.27% of all US stocks.
- To contextualize these metrics, consider that out of stocks in the small market cap category, REPARE THERAPEUTICS INC's number of analysts covering the stock is higher than 2510.4% of them.
- REPARE THERAPEUTICS INC's average analyst price target is higher than 2225.68% of stocks in the small market cap category.
Stocks similar to REPARE THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are IVA, ANNX, and NRIX.
View All Top Stocks by Price Target
Is RPTX a Buy, Hold or Sell? See the POWR Ratings now!